tirzepatide compounding pharmacy oregon Oral | Starts at $279/mo Tirzepatide Injection | Starts at

Big pharma is currently facing a potential bubble effect due to the surging demand for weight loss and diabetes drugs, as revealed in a report by Deloitte released on Monday

74% of people who quit a GLP-1 plan to restart within a year (NPR, 2026)

Better yet, our product is pregnancy safe and great for people of all ages and walks of life whether that be toddlers, children, teens, adults, or seniors looking for protein

CagriSema is a fixed-dose combination of cagrilintide (an amylin analogue) and semaglutide (a GLP-1 receptor agonist), and is currently an experimental obesity drug developed by Novo Nordisk

Built around Akkermansia Muciniphila, a cutting edge probiotic strain, this formulation focuses on strengthening the gut lining and improving overall microbiome balance